載入...
Mycophenolate mofetil reduces STAT3 phosphorylation in systemic lupus erythematosus patients
Systemic lupus erythematosus (SLE) is a highly variable autoimmune disease that can involve severe organ-threatening symptoms, such as lupus nephritis. Certain drugs, such as mycophenolate mofetil (MMF), are effective at reducing morbidity associated with nephritis; however, the immune pathways asso...
Na minha lista:
| 發表在: | JCI Insight |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Clinical Investigation
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6413783/ https://ncbi.nlm.nih.gov/pubmed/30674728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.124575 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|